Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-12-03
2008-11-18
Stucker, Jeffrey (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C424S093510, C435S254210, C435S255100, C435S255200, C435S029000
Reexamination Certificate
active
07452670
ABSTRACT:
Methods of screening candidate agents to identify lead compounds for the development of therapeutic agents for the treatment of a neurodegenerative disease, such as Huntington's Disease and Parkinson's Disease and methods for identifying a mutation in, or changes in expression of, a gene associated with neurodegenerative disease, such as Huntington's Disease and Parkinson's Disease, are provided.
REFERENCES:
patent: WO 02/065136 (2002-08-01), None
Moore et al. Annu. Rev. Neurosci. 2005. 28: 57-87.
Ambrose et al., “Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat,”Somat. Cell Mol. Genet. 20:27-38 (1994).
Clayton and George, “Synucleins in synaptic plasticity and neurodegenerative disorders,”J. Neurosci. Res.58:120-129 (1999).
Cummings et al., “Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function inSCAImice,”Hum. Mol. Genet.10:1511-1518 (2001).
Engelender et al., “Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions, ”Nat. Genet.22:110-114 (1999).
Fernandez-Funez et al., “Identification of genes that modify ataxin-1-induced neurodegeneration,”Nature408:101-106 (2000).
George et al., “Characterization of a novel protein regulated during the critical period for song learning in the zebra finch,”Neuron15:361-372 (1995).
Goedert, “Alpha-synuclein and neurodegenerative diseases,”Nat. Rev. Neurosci.2:492-501 (2001).
Grunenfelder and Winzeler, “Treasures and traps in genome-wide data sets: case examples from yeast,”Nat. Rev. Genet.3:653-61 (2002).
Gusella and MacDonald, “Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease,”Nat. Rev. Neurosci. 1:109-115 (2000).
Hardy and Selkoe, “The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics,”Science297:353-356 (2002).
Huntington's Disease Collaborative Research Group, “A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes,”Cell72:971-983 (1993).
Kazemi-Esfarjani and Benzer, “Genetic suppression of polyglutamine toxicity inDrosophila,”Science287:1837-1840 (2000).
Kruger et al., “Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease,”Nat. Genet.18:106-08 (1998).
Lotharius and Brundin, “Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein,”Nat. Rev. Neurosci. 3:932-942 (2002).
Muchowski et al., “Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloids-like fibrils,”Proc. Natl. Acad. Sci. USA97:7841-7846 (2000).
Polymeropoulos et al., “Mutation in the α-synuclein gene identified in families with Parkinson's Disease,”Science276:2045-2047 (1997).
Rochet and Lansbury Jr., “Amyloid Fibrillogenesis: themes and variations,”Curr. Opin. Struct. Biol.10:60-88 (2000).
Scherzinger et al., “Huntington-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo,”Cell90:549-558 (1997).
Volles et al., “Vesicle permeabilization by protofibrillar α-synuclein: implications for the pathogenesis and treatment of Parkinson'disease,”Biochemistry40:7812-7819 (2001).
Warrick et al., “Suppression of polyglutamine-mediated neurodegeneration inDrosophilaby the molecular chaperone HSP70,”Nat. Genet.23:425-428 (1999).
Zoghbi and Orr, “Glutamine repeats and neurodegeneration,”Ann. Rev. Neurosci.23:217-247 (2000).
Lindquist Susan L.
Muchowski Paul J.
Outeiro Tiago
Stucker Jeffrey
Townsend and Townsend / and Crew LLP
University of Washington
Wang Chang-Yu
Whitehead Institute for Biomedical Research
LandOfFree
Methods of identifying agents that diminish cellular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying agents that diminish cellular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying agents that diminish cellular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024948